文献速递糖尿病垂体与肾上腺疾病

糖尿病合并重度慢性肾脏病患者中糖化血红蛋白与并发症的关联

The Association Between Hemoglobin A1c and Complications Among Individuals With Diabetes and Severe Chronic Kidney Disease.
PubMed 文献 · Diabetes Care · 2025-01-01

丹麦全国登记队列研究纳入27113例糖尿病合并重度CKD(eGFR<30 mL/min/1.73 m2)患者,并设两个匹配对照队列。以HbA1c 6.3-6.6%(45-49 mmol/mol)为参照,HbA1c≥7.2%(55 mmol/mol)与<5.8%(40 mmol/mol)时主要不良心血管事件风险显著升高。作者认为HbA1c 6.7-7.1%(50-54 mmol/mol)范围可能最有利于减少长期并发症。

要点

  • 重度CKD患者HbA1c≥7.2%或<5.8%时MACE风险较6.3-6.6%显著升高。
  • HbA1c≥7.2%时微血管并发症风险显著升高。
  • HbA1c≥6.7%时因低血糖住院风险显著升高。

核心结论

  • 作者认为HbA1c 6.7-7.1%(50-54 mmol/mol)范围可能最有利于减少该高危人群的长期并发症。

研究设计与样本

  • 丹麦全国登记为基础的队列研究,纳入2010至2022年间27113例≥18岁糖尿病合并重度CKD(eGFR<30 mL/min/1.73 m2)患者。
  • 设年龄和性别匹配的对照队列:糖尿病合并轻中度CKD(eGFR 30-59 mL/min/1.73 m2)80131例,及糖尿病合并无至轻度CKD(eGFR≥60 mL/min/1.73 m2)80797例。
  • 采用多重Cox回归估计不同HbA1c水平分层下主要不良心血管事件(MACE)、微血管并发症及因低血糖住院的标准化1年风险。

主要发现

  • 重度CKD患者中,与HbA1c 6.3-6.6%(45-49 mmol/mol)相比,HbA1c≥7.2%(55 mmol/mol)时MACE风险显著升高(P<0.01),HbA1c<5.8%(40 mmol/mol)时MACE风险亦显著升高(P<0.001)。
  • 重度CKD患者中,HbA1c≥7.2%(55 mmol/mol)时微血管并发症风险显著升高(P<0.001)。
  • 重度CKD患者中,HbA1c≥6.7%(50 mmol/mol)时因低血糖住院风险显著升高(P<0.001)。
  • 重度CKD队列中HbA1c与结局的关联模式与轻中度CKD及无至轻度CKD匹配队列相似。

关键数值与推荐

  • 重度CKD患者MACE风险升高的HbA1c阈值为≥7.2%(55 mmol/mol)(P<0.01)和<5.8%(40 mmol/mol)(P<0.001),参照为6.3-6.6%(45-49 mmol/mol)。
  • 重度CKD患者微血管并发症风险升高的HbA1c阈值为≥7.2%(55 mmol/mol)(P<0.001)。
  • 重度CKD患者因低血糖住院风险升高的HbA1c阈值为≥6.7%(50 mmol/mol)(P<0.001)。
  • 作者提出HbA1c 6.7-7.1%(50-54 mmol/mol)范围可能最有利。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The optimal glycemic target for individuals with severe chronic kidney disease (CKD) remains unclear. We investigated the association between HbA1c and complications in individuals with diabetes and severe CKD. RESEARCH DESIGN AND METHODS: In a Danish nationwide registry-based cohort study, we included 27,113 individuals ≥18 years old with diabetes and severe CKD (estimated glomerular filtration rate [eGFR] <30 mL/min/1.73 m2) between 2010 and 2022. As reference groups, we included an age- and sex-matched cohort of 80,131 individuals with diabetes and mild-to-moderate CKD (eGFR 30-59 mL/min/1.73 m2) and 80,797 individuals with diabetes and no-to-mild CKD (eGFR ≥60 mL/min/1.73 m2). Multiple Cox regressions were used to estimate the standardized 1-year risk of major adverse cardiovascular events (MACE), microvascular complications, and hospitalizations due to hypoglycemia across strata of HbA1c levels. RESULTS: For individuals with severe CKD, the risk of MACE significantly increased at HbA1c levels ≥7.2% (55 mmol/mol) (P < 0.01) and <5.8% (40 mmol/mol) (P < 0.001), compared with an HbA1c level of 6.3-6.6% (45-49 mmol/mol). The risk of microvascular complications significantly increased at HbA1c levels ≥7.2% (55 mmol/mol) (P < 0.001), and the risk of hospitalization due to hypoglycemia significantly increased at HbA1c levels ≥6.7% (50 mmol/mol) (P < 0.001). The association patterns between HbA1c and outcomes were similar in the severe CKD cohort compared with the matched cohorts with mild-to-moderate CKD and no-to-mild CKD. CONCLUSIONS: Our data suggest an HbA1c range of 6.7-7.1% (50-54 mmol/mol) to be most favorable for reducing long-term complications in this high-risk population.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kofod DH, Carlson N, Almdal TP, et al. The Association Between Hemoglobin A1c and Complications Among Individuals With Diabetes and Severe Chronic Kidney Disease. Diabetes Care. 2025. PMID: 40481664. doi:10.2337/dc25-0339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。